Columbus-based Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute has named Ann-Kathrin Eisfeld, MD, director of precision genomics clinical transformation.
OSUCCC-James CEO Kimryn Rathmell, MD, PhD, shared news of the appointment in a July 12 LinkedIn post.
Dr. Eisfeld also serves as director of the Clara D. Bloomfield Center for Leukemia Outcomes Research, Dr. Rathmell said in the post.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.